ArticleTherapeutic delivery2025

Development and evaluation of targeted liposomes for improved doxorubicin and quercetin delivery for MDR breast cancer.

Shreastha Gautam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.